Barrier Seeks Development Partner For Its Liarozole Treatment In Lamellar Ichthyosis
This article was originally published in The Pink Sheet Daily
Executive Summary
Phase II/III trial fails to meet primary endpoint; FDA and EMEA want more clinical trials, firm tells “The Pink Sheet” DAILY.